FDA Warning on Semaglutide, B/Yamagata Flu Strain Disappearance, and Athlete Mental Health

In today's episode, Dr. Chi-Ming Chow introduces the discussion with an FDA warning about adverse events related to compounded semaglutide and shares the agency's recommendations along with Novo Nordisk's legal actions. He reviews a study on semaglutide's effects on tobacco use disorder. The episode also covers the disappearance of the B/Yamagata influenza strain. Dr. Chow addresses mental health challenges faced by Olympic athletes and provides professional athletes' tips for an injury-free return to sports. Expert advice on enhancing strength, speed, and mobility for athletes is also discussed. The episode concludes with a wrap-up.